Covid Vaccine: The country’s first nasal vaccine, Bharat Biotech Nasal Vaccine has been approved by DCGI

Bharat Biotech Nasal Vaccine:  Bharat Biotech Intranasal

Bharat Biotech gets emergency use authorization from DCGI for intranasal #COVID19 vaccine: Union Health Minister Dr Mansukh Mandaviya

This will be India’s first nasal vaccine for COVID pic.twitter.com/LZDoVwa5bI

— ANI (@ANI) September 6, 2022

 Mansukh Mandavya said that people aged 18 years and above can use this vaccine in emergency situations.

Central Health Minister Dr. Mansukh Mandavya tweeted that India’s fight against Covid-19 has received a big boost.

Big Boost to India’s Fight Against COVID-19!

Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation.

— Dr Mansukh Mandaviya (@mansukhmandviya) September 6, 2022

He further said that this step will further strengthen our collective fight against the epidemic. Under the leadership of the Prime Minister of India, Narendra Modi, the fight against Covid-19 has utilized  knowledge, research and development and human resources.

This step will further strengthen our collective fight against the pandemic.

India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji’s leadership.

With the science-driven approach & Sabka Prayas, we will defeat COVID-19.

— Dr Mansukh Mandaviya (@mansukhmandviya) September 6,

Note: You can download our app to read breaking news in Punjabi. If you want to watch videos, then subscribe to ABP’s YouTube channel. ABP sharing is available on all social media platforms. You can also follow us on Facebook, Twitter, Ku, ShareChat and DailyHunt.

Get the more latest news about India